VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-29373 | Semiconductor and Electronics
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Ventilator Associated Pneumonia (VAP) Therapeutics Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET
7.1 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Savara Pharmaceuticals
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Serendex Pharmaceuticals
16.3 Cardeas Pharma
16.4 Nabriva Therapeutics
16.5 Tetraphase Pharmaceuticals
16.6 Aridis Pharmaceuticals
16.7 MedImmune
16.8 Merck
16.9 Adenium Biotech
16.10 Dong-A Socio
16.11 AstraZeneca
16.12 Meiji Seika Pharma
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Most important types of Ventilator Associated Pneumonia (VAP) Therapeutics products covered in this report are:Prevention
Physiotherapy
Immunity Therapy
Other
Most widely used downstream fields of Ventilator Associated Pneumonia (VAP) Therapeutics market covered in this report are:
Hospitals
Ambulatory Surgical Center
Diagnostic Centers
Other
Companies
Savara Pharmaceuticals
Serendex Pharmaceuticals
Cardeas Pharma
Nabriva Therapeutics
Tetraphase Pharmaceuticals
Aridis Pharmaceuticals
MedImmune
Merck
Adenium Biotech
Dong-A Socio
AstraZeneca
Meiji Seika Pharma
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.